AmCham-IMSS deal pledges US $44 million to bring clinical trials to Mexican public hospitals
The vast majority of clinical trials in Mexico for testing, among other things, the safety and efficacy of new medications, take place in private hospitals. AmCham and IMSS are looking to change that. The post AmCham-IMSS deal pledges US $44 million to bring clinical trials to Mexican public hospitals appeared first on Mexico News Daily
The Mexican Social Security Institute (IMSS) and the American Chamber of Commerce of Mexico (AmCham) have signed a deal to invest over US $44 million in clinical trials within public hospitals from 2026 to 2030. The agreement, involving 11 pharmaceutical companies, aims to increase the number of clinical trials conducted in IMSS's hospital network, which boasts over 1,800 medical facilities serving approximately 70 million beneficiaries.
IMSS Director General Zoé Robledo emphasized the unique capabilities of the public hospitals, stating that they offer at least as much as private hospitals, if not more. The initiative intends to translate research findings into improved patient care, particularly for high-prevalence or complex conditions such as diabetes, hypertension, cancer, kidney disorders, neurological diseases, and rare diseases.
Brief written by urgent.news from Mexico News Daily's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
